Streetbeat News

Revenues

CTKB

Cytek Biosciences has revised its FY24 revenue outlook to $203M-$210M from the previous $203M-$213M, with an estimated $208.801M. The company now expects to report a net loss in the single-digit millions for FY24, instead of a positive net income, due to slightly lower gross profit, higher stock-based compensation, and lower other income. However, Cytek anticipates generating positive cash flow from operations in 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:21 pm

MYGN

Myriad Genetics has announced its FY24 gross revenue forecast to be between $835 million and $845 million, surpassing the previous estimate of $831 million.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:20 pm

BRDG

Bridge Investment Group (NYSE:BRDG) reported Q2 2024 earnings of $0.19 per share, beating the analyst estimate of $0.18. Sales were $104.760 million, surpassing the $87.950 million estimate. Despite a 5% decrease in EPS from last year, sales increased by 6.03%.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:19 pm

STEM

Stem Inc. has significantly revised its FY24 revenue guidance downwards to $200M-$270M from the previous $567M-$667M, with a new estimate of $599M. Other financial metrics such as non-GAAP gross margin, adjusted EBITDA, bookings, CARR, and operating cash flow have also been updated.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:18 pm

MEC

Mayville Engineering (NYSE:MEC) reported Q2 2024 adjusted EPS of $0.26, beating the estimate of $0.19 by 36.84%. Sales were $163.636M, surpassing the $159.116M estimate and marking a 17.74% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:18 pm

BWMN

Bowman Consulting Group Ltd. (BWMN) has updated its FY 2024 guidance, projecting net service billing between $375M and $385M and Adjusted EBITDA between $58M and $63M. This outlook is based on completed acquisitions to date and excludes future acquisitions.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:17 pm

SSTI

SoundThinking reaffirms its FY24 revenue guidance range of $104M to $106M, with an estimated $105.036M. The company also expects Adjusted EBITDA margins of 18% to 20% for the full year 2024.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:17 pm

FTEK

Fuel Tech, Inc. (NASDAQ:FTEK) has received air pollution control orders totaling $5 million from new and existing customers in Europe and the U.S., including its first APC award for a renewable energy project.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:17 pm

HRTX

Heron Therapeutics has reaffirmed its FY24 product revenue expectations, net of $138M - $158M, with an estimated $147.855M. The company has also narrowed its guidance for adjusted operating expenses and adjusted EBITDA.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:15 pm

STHO

Star Holdings (NASDAQ: STHO) reported Q2 earnings per share (EPS) of $(2.04), a significant improvement from $(6.75) YoY. Sales increased by 19.90% to $30.55 million from $25.48 million YoY.

Portfolio Pulse from Benzinga Newsdesk

August 06, 2024 | 9:15 pm